U.S. Vaccine Packaging Market - Focused Insights 2023-2028

The U.S. vaccine packaging market, valued at USD 923.71 million in 2022, is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.99% and reach USD 1,385.65 million by 2028. The U.S. vaccine market has experienced significant progress over the past decades, mainly due to a heightened focus on research and development, especially for immunological disorders. With federal government funding, several public agencies and programs are involved in vaccine-related activities, including infant vaccination, which has proven to be an effective public health strategy to control and prevent diseases. 

MARKET DRIVERS 

Prevalence of Infectious Diseases and Immunology Disorders: The rise in the incidences of various viral infections and immunological disorders, such as COVID-19, among the population in the U.S. is one of the major factors driving the growth of the vaccine packaging market. In recent years, the rapid spread of severe infections such as SARS, Ebola, and HIV has highlighted the need for global preparedness for pandemics, which leads to extremely rapid development and extensive distribution of vaccines. This forces pharmaceutical manufacturers to speed up their vaccine manufacturing process to meet urgent demands. Hence, packaging vaccines becomes necessary from the moment they are manufactured until they are dispensed. Immunological diseases are among the leading causes of death among young and middle-aged women in the U.S.  

Increasing Government Expenditure on Immunization Programs: Growing healthcare expenditure by healthcare organizations and biopharma firms in vaccine research and development and growing government expenditure in immunization programs boost the market growth. The U.S. government, for instance, sponsors numerous federal organizations and initiatives engaged in vaccination-related activities. The government spends hundreds of millions per year on vaccination research and production to procure and administer vaccines to the states, ensure the protection of approved vaccines, and perform educational and other promotional initiatives to assist the use of vaccines. 

U.S. VACCINE PACKAGING MARKET INSIGHTS  

• Primary packaging is growing significantly, with the fastest CAGR of 7.15% of the U.S. vaccine packaging market during the forecast period. The growth of this segment can be attributed to the growing demand for vials, ampoules, and syringes with the increasing demand for vaccines. 
• Based on primary packaging type, the vials packaging segment accounted for a major market share in the U.S. vaccine packaging market. It dominated the other segments due to its wide usage as an essential primary packaging element for vaccine products.  
• Based on material type, the glass segment is growing with the highest CAGR in the U.S. vaccine packaging market during the forecast period. The growth can be attributed to its external barrier properties and its highest demand in primary packaging.  
• In 2022, the U.S. accounted for a significant market share in the North American vaccine packaging market which is due to increasing research and development (R&D) activities owing to the prevalence of various infectious diseases, the presence of leading pharmaceutical players, high investments in drug development, well-developed infrastructure as well as substantial involvement of government in vaccination programs.    
• The pharmaceutical and biotech companies accounted for the highest share of more than 46% in the U.S. vaccine packaging market, which is owing to the rise in contagious or infectious diseases, the growing aging population, the growing demand for vaccines, and innovations in vaccine development are some of the major factors driving the vaccine packaging industry.  

VENDOR LANDSCAPE  

The U.S. vaccine packaging market report contains exclusive data on 25 vendors. The competitive landscape in the U.S. vaccine packaging market is intensifying, with global players offering a diverse range of products. Dominant players include SCHOTT Pharma, Gerresheimers AG, Stevanato Group, SGD Pharma, WestRock Pharma, Amcor, Aptar Group, Corning International, Catalent, Becton, Dickinson and Company (B.D.), and Panasonic Health Corporation. They primarily focus on strategic acquisitions, licensing, and collaboration agreements with emerging players to enter the vaccine packaging market and gain access to commercially launched products.